Download 2021 UDS Code Changes for Table 6A and more Summaries Nursing in PDF only on Docsity!
UDS Table 6A Code Changes
Table 6A: Selected Diagnoses and Services Rendered
* Indicates change from 2020
Line Diagnosis/Service 2020 Codes 2021 Codes
blank (^) Selected Infectious and Parasitic
Diseases
blank blank
Symptomatic/Asymptomatic human immunodeficiency virus (HIV)
B20, B97.35, O98.7‐, Z21 B20, B97.35, O98.7‐, Z
3 Tuberculosis A15‐ through A19‐, O98.0‐ A15‐ through A19‐, O98.0‐ 4 Sexually transmitted infections A50‐ through A64‐ A50‐ through A64‐
4a Hepatitis B
B16.0 through B16.2, B16.9, B17.0, B18.0, B18.1, B19.1‐, O98.4‐
B16.0 through B16.2, B16.9, B17.0, B18.0, B18.1, B19.1‐, O98.4‐ 4b Hepatitis C B17.1‐, B18.2, B19.2‐ B17.1‐, B18.2, B19.2‐
4c Novel coronavirus (SARSdisease ‐CoV‐2) U07.1 U07.
blank Selected Diseases of the Respiratory System
blank blank
5 Asthma J45‐ J45‐
6 Chronic lower respiratory diseases
J40 (count only when code U07.1 is not present), J41‐ through J44‐, J47‐
J40 (count J40 only when code U07.1 is not present), J41‐ through J44‐, J47‐
6a
Acute respiratory illness due to novel coronavirus (SARS‐CoV‐2) disease
J12.89, J20.8, J40, J22, J98.8, J
(count only when code U07.1 is present)
J12.89, J20.8, J40 (count J only when code U07.1 is present), J22, J98.8, J
blank Selected Other Medical Conditions
blank blank
7 Abnormal breast findings, female
C50.01‐, C50.11‐, C50.21‐,
C50.31‐, C50.41‐, C50.51‐,
C50.61‐, C50.81‐, C50.91‐,
C79.81, D05‐, D48.6‐, D49.3,
N60‐, N63‐, R92‐
C50.01‐, C50.11‐, C50.21‐,
C50.31‐, C50.41‐, C50.51‐,
C50.61‐, C50.81‐, C50.91‐,
C79.81, D05‐, D48.6‐, D49.3,
N60‐, N63‐, R92‐
8 Abnormal cervical finding C R87.629, R87.810, R87.82053‐, C79.82, D06‐, R87.61‐,^ C R87.629, R87.810, R87.82053‐, C79.82, D06‐, R87.61‐,
9 Diabetes mellitus E (exclude O24.4108‐^ through E13‐‐), O24‐^ E (exclude O24.4108‐^ through E13‐‐), O24‐
10 Heart disease (selected)
I01‐, I02‐ (exclude I02.9), I20‐ through I25‐, I27‐, I28‐, I30‐ through I52‐
I01‐, I02‐ (exclude I02.9), I20‐ through I25‐, I27‐, I28‐, I30‐ through I52‐ 11 Hypertension I10‐ through I16‐, O10‐, O11‐ I10‐ through I16‐, O10‐, O11‐
Contact dermatitis and other eczema
L23‐ through L25‐, L30‐ (exclude L30.1, L30.3, L30.4, L30.5), L58‐
L23‐ through L25‐, L30‐ (exclude L30.1, L30.3, L30.4, L30.5), L58‐
13 Dehydration E86‐ E86‐
14 Exposure to heat or cold T33‐, T34‐, T67‐, T68‐, T69‐,
W92‐, W93‐
T33‐, T34‐, T67‐, T68‐, T69‐,
W92‐, W93‐, X30‐, X31‐, X32‐
14a Overweight and obesity
E66‐, Z68‐ (exclude Z68.1, Z68.20 through Z68.24, Z68.51, Z68.52)
E66‐, Z68‐ (exclude Z68.1, Z68.20 through Z68.24, Z68.51, Z68.52)
blank (^) Selected Childhood Conditions (limited to ages 0 through 17)
blank blank
15 Otitis media and Eustachian tube
disorders
H65‐ through H69‐ H65‐ through H69‐
16 Selected perinatal/neonatal
medical conditions
A33‐, P19‐, P22‐ through P29‐ (exclude P29.3), P35‐ through P96‐ (exclude P54‐, P91.6‐, P92‐ , P96.81), R78.81, R78.
A33, P19‐, P22‐ through P29‐ (exclude P29.3‐), P35‐ through P96‐ (exclude P54‐, P91.6‐, P92‐ , P96.81), R78.81, R78.
Lack of expected normal
physiological development (such
as delayed milestone, failure to
gain weight, failure to thrive);
nutritional deficiencies in
children only. Does not include
sexual or mental development.
E40‐ through E46‐, E50‐ through E63‐, P92‐, R62‐ (exclude R62.7), R63.
E40‐ through E46‐, E50‐ through E63‐, P92‐, R62‐ (exclude R62.7), R63.
blank Selected Mental Health Conditions, Substance Use Disorders, and Exploitations
blank blank
18 Alcohol‐related disorders F10‐, G62.1, O99.31‐ F10‐, G62.1, O99.31‐
Other substance‐related
disorders (excluding tobacco use
disorders)
F11‐ through F19‐ (exclude F17‐ ), G62.0, O99.32‐
F11‐ through F19‐ (exclude F17‐ ), G62.0, O99.32‐
19a Tobacco use disorder F17‐, O99.33‐ F17‐, O99.33‐
21c Novel coronavirus (SARS‐CoV‐2)
diagnostic test
CPT‐4: 87426, 87635
HCPCS: U0001, U0002, U0003,
U
CPT PLA: 0202U, 0223U, 0225U
CPT‐4: 87426, 87635, 87636, 87637 HCPCS: U0001, U0002, U0003, U CPT PLA: 0202U, 0223U, 0225U, 0240U, 0241U
21d
Novel coronavirus (SARS‐CoV‐2)
antibody test
CPT‐4: 86328, 86408, 86409,
CPT PLA: 0224U, 0226U
CPT‐4: 86328, 86408, 86409,
CPT PLA: 0224U, 0226U
21e
Pre‐Exposure Prophylaxis (PrEP)‐
associated management of all
PrEP patients
CPT‐4: 99401 ‐ 99404
ICD‐10: Z11.3, Z11.4, Z20.2,
Z20.6, Z51.81, Z71.51, Z71.7,
Z79.
Limit to emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) or emtricitabine/tenofovir alafenamide (FTC/TAF) for PrEP
CPT‐4: 99401 ‐ 99404
ICD‐10: Z11.3, Z11.4, Z20.2,
Z20.6, Z51.81, Z71.51, Z71.7,
Z79.
Limit to emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) or emtricitabine/tenofovir alafenamide (FTC/TAF) for PrEP
22 Mammogram CPT‐4:^ 77065, 77066, 77067
ICD‐10: Z12.
CPT‐4: 77063, 77065, 77066,
ICD‐10: Z12.
HCPCS: G
23 Pap test
CPT‐4: 88141 through 88153, 88155, 88164 through 88167, 88174, 88175 ICD‐10: Z01.41‐, Z01.42, Z12. (exclude Z01.411, and Z01.419)
CPT‐4: 88141 through 88153, 88155, 88164 through 88167, 88174, 88175 ICD‐10: Z01.41‐, Z01.42, Z12. (exclude Z01.411, and Z01.419)
Selected immunizations:
hepatitis A; haemophilus
influenzae B (HiB);
pneumococcal, diphtheria,
tetanus, pertussis (DTaP) (DTP)
(DT); measles, mumps, rubella
(MMR); poliovirus; varicella;
hepatitis B
CPT‐4: 90632, 90633, 90634,
CPT‐4: 90632, 90633, 90634,
24a Seasonal flu vaccine
CPT‐4: 90630, 90653 through 90657, 90658, 90661, 90662, 90672, 90673, 90674, 90682, 90685 through 90689, 90756
CPT‐4: 90630, 90653 through 90657, 90658, 90661, 90662, 90672, 90673, 90674, 90682, 90685 through 90689, 90756
24b
Coronavirus (SARS‐CoV‐2)
vaccine
Blank for demonstration CPT‐I : 0001A-004A,^ 0011A- 0014 A, 0021A-0 024 A, 0031A- 0034A, 0041A-0044A, 9130 0, 91301 , 91302, 91303, 91304
25 Contraceptive management ICD‐10: Z30‐ ICD‐10: Z30‐
Health supervision of infant or
child (ages 0 through 11)
CPT‐4: 99381 through 99383, 99391 through 99393 ICD‐10: Z00.1‐
CPT‐4: 99381 through 99383, 99391 through 99393 ICD‐10: Z00.1‐, Z76.1, Z76.
26a
Childhood lead test screening (
to 72 months)
ICD‐10: Z13.
CPT‐4: 83655
ICD‐10: Z13.
CPT‐4: 83655
26b
Screening, Brief Intervention,
and Referral to Treatment
(SBIRT)
CPT‐4: 99408, 99409
HCPCS: G0396, G0397, G0443,
H
CPT‐4: 99408, 99409
HCPCS: G0396, G0397, G0443,
H
